Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure

BACKGROUND: A vaccine trial with a conventional challenge design can be very fast once it starts, but it requires a long prior process, in part to grow and standardize challenge virus in the laboratory. This detracts somewhat from its overall promise for accelerated efficacy testing of severe acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyal, Nir, Lipsitch, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787506/
https://www.ncbi.nlm.nih.gov/pubmed/33421580
http://dx.doi.org/10.1016/j.cmi.2020.12.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787506/
https://www.ncbi.nlm.nih.gov/pubmed/33421580
http://dx.doi.org/10.1016/j.cmi.2020.12.032

Ejemplares similares